Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A2YNT30
Mon, 11.03.2024
Alzchem Group AG
EQS-Media / 11.03.2024 / 11:15 CET/CEST
Crearene AG and Alzchem Group AG: Successful addition of creatine to dialysis patient treatments
As part of their cooperation, Alzchem Group AG and Crearene AG announced in October 2023 that a clinical study on the use of creatine in dialysis treatments had been launched. The aim is to demonstrate the t [ … ]
Fri, 01.03.2024
Alzchem Group AG
Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million – continuing on the road to success
High-growth specialty chemicals business proves to be a key earnings driver and important sales pillar
Dividend increase to EUR 1.20 planned
Forecast for 2024 envisages rise in sales and EBITDA
Trostberg, March 1, 2024 – Alzchem Group AG, a verti [ … ]
Thu, 11.01.2024
Alzchem Group AG
EQS-Media / 11.01.2024 / 15:28 CET/CEST
Long-Covid: New clinical studies show high efficacy of creatine supplementation
Creatine is a natural, endogenous substance that plays a central role as an energy transporter and buffer in every cell. It is an essential component of cellular energy metabolism and is therefore important for all energy-i [ … ]
Wed, 13.12.2023
Alzchem Group AG
EQS-Media / 13.12.2023 / 14:09 CET/CEST
Alzchem awarded for sustainable supply chains: Outstanding result certified by "Together for Sustainability (TfS)" initiative
With 192 out of a possible 200 points, Alzchem ranks very high in the audit of the industry initiative "Together for Sustainability (TfS)". This certifies that the specialty chem [ … ]
Fri, 08.12.2023
Alzchem Group AG
Alzchem Group AG expands Management Board: Supervisory Board appoints Andreas Lösler as new CFO with effect from 1 January 2024
Trostberg, December 8, 2023 – Alzchem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, is expanding its Management Board team. At its meeting on 5 De [ … ]
Thu, 26.10.2023
Alzchem Group AG
Alzchem Group AG significantly increases EBITDA by 19.8% to EUR 56.3 million in the nine-month period 2023
Sales growth in Specialty Chemicals segment supports increased EBITDA margin of 14.2%
Free cash flow rises significantly to EUR 30.5 million
Adjusted forecast 2023: Strong EBITDA growth to approx. EUR 80 million, sales stable at previous ye [ … ]
Thu, 14.09.2023
Alzchem Group AG
EQS-Media / 14.09.2023 / 11:08 CET/CEST
Creatine product "Creavitalis": Wholesome taste and positive benefits for vegetarian and vegan foods
Meat substitutes are very much in vogue. Burgers, bratwurst, cold cuts - there is hardly a product for which there is not now a meat-free variant. Manufacturers of plant-based alt [ … ]
Thu, 03.08.2023
Alzchem Group AG
Alzchem Group AG reports positive business development in the first half of 2023
Sales increase by 3% to EUR 277.0 million
EBITDA grows by 5% to EUR 36.8 million
Strong free cash flow of EUR 31.3 million
Forecast confirmed: for the full year, sales expected to be at the lower end of the range, EBITDA at the upper end of the range
Trostberg, Au [ … ]
Thu, 03.08.2023
Alzchem Group AG
Alzchem Group AG reports positive business development in the first half of 2023
Sales increase by 3% to EUR 277.0 million
EBITDA grows by 5% to EUR 36.8 million
Strong free cash flow of EUR 31.3 million
Forecast confirmed: for the full year, sales expected to be at the lower end of the range, EBITDA at the upper end of the range
Trostberg, Au [ … ]
Fri, 12.05.2023
Alzchem Group AG
Alzchem Group AG ensures continuity on the Management Board: Contract extension with CEO Andreas Niedermaier until 2026
Trostberg, 12 Mai 2023 – The Supervisory Board of Alzchem Group AG has extended early the service contract of Chief Executive Officer Andreas Niedermaier, which runs until 31 December 2023, by 3 years until 2026. The vertically i [ … ]